ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 167 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,360 | -54.2% | 13,633 | -35.0% | 0.00% | – |
| Q2 2023 | $29,161 | -12.6% | 20,979 | 0.0% | 0.00% | – |
| Q1 2023 | $33,357 | -54.4% | 20,979 | +78.7% | 0.00% | – |
| Q4 2022 | $73,122 | -14.0% | 11,737 | -7.0% | 0.00% | – |
| Q3 2022 | $85,000 | -75.4% | 12,617 | -4.8% | 0.00% | -100.0% |
| Q4 2020 | $345,000 | -92.9% | 13,258 | -89.8% | 0.00% | -92.9% |
| Q3 2020 | $4,832,000 | -32.0% | 130,006 | -6.2% | 0.01% | -36.4% |
| Q2 2020 | $7,110,000 | +113.9% | 138,577 | +31.4% | 0.02% | +83.3% |
| Q1 2020 | $3,324,000 | -30.7% | 105,439 | +31.1% | 0.01% | -14.3% |
| Q4 2019 | $4,797,000 | +479600.0% | 80,452 | +423331.6% | 0.01% | – |
| Q4 2018 | $1,000 | 0.0% | 19 | 0.0% | 0.00% | – |
| Q3 2018 | $1,000 | -75.0% | 19 | -81.0% | 0.00% | – |
| Q2 2018 | $4,000 | -96.9% | 100 | -94.4% | 0.00% | – |
| Q1 2018 | $128,000 | +68.4% | 1,775 | +53.0% | 0.00% | – |
| Q4 2017 | $76,000 | +49.0% | 1,160 | +13.7% | 0.00% | – |
| Q3 2017 | $51,000 | -58.2% | 1,020 | -80.3% | 0.00% | -100.0% |
| Q3 2015 | $122,000 | +3966.7% | 5,182 | +13187.2% | 0.00% | – |
| Q2 2015 | $3,000 | – | 39 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $27,840,842 | 18.82% |
| Ikarian Capital, LLC | 1,891,147 | $11,781,846 | 2.84% |
| Altium Capital Management LP | 620,000 | $3,862,600 | 1.96% |
| Ikarian Capital, LLC | 1,296,900 | $8,079,687 | 1.95% |
| Parkman Healthcare Partners LLC | 822,784 | $5,125,944 | 1.36% |
| Deep Track Capital, LP | 4,000,000 | $24,920,000 | 1.05% |
| Monaco Asset Management SAM | 470,100 | $2,928,723 | 0.88% |
| BRAIDWELL LP | 3,393,405 | $21,140,913 | 0.71% |
| Telemetry Investments, L.L.C. | 71,000 | $442 | 0.70% |
| Rhenman & Partners Asset Management AB | 900,000 | $5,607,000 | 0.58% |